BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 6697040)

  • 21. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical diagnosis of vaginal adenosis.
    Stafl A; Mattingly RF; Foley DV; Fetherston WC
    Obstet Gynecol; 1974 Jan; 43(1):118-28. PubMed ID: 4808952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinicopathologic study of vagina and cervix in DES-exposed progeny.
    Zerner J; Fu YS; Taxiarchis LN; Reagan JW; Richart RM
    Diagn Gynecol Obstet; 1980; 2(4):245-56. PubMed ID: 7215109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stilboestrol and human cancer.
    Bishun NP; Smith NS; Williams DC
    Clin Oncol; 1977 Mar; 3(1):75-80. PubMed ID: 862278
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormalities of the genital tract following stilbestrol exposure in utero.
    Kurman RJ
    Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Teratogenic effect of diethylstilbestrol during pregnancy; the extent of the DES problem in the Netherlands].
    Stolk JG; Vooijs GP; Aartsen EJ; Heintz AP
    Ned Tijdschr Geneeskd; 1982 Jul; 126(30):1350-8. PubMed ID: 7133167
    [No Abstract]   [Full Text] [Related]  

  • 29. [The stilbestrol--adenosis--carcinoma--syndrome. A review].
    Ulfelder H
    Geburtshilfe Frauenheilkd; 1975 May; 35(5):329-33. PubMed ID: 1150064
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    Adam E; Decker DG; Herbst AL; Noller KL; Tilley BC; Townsend DE
    Cancer Res; 1977 Apr; 37(4):1249-51. PubMed ID: 844051
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification and management of DES-exposed women.
    Vieiralves-Wiltgen C; Engle VF
    Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Med Assoc State Ala; 1977 Mar; 46(9):39-41. PubMed ID: 845523
    [No Abstract]   [Full Text] [Related]  

  • 33. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
    Piver MS; Lele SB; Baker TR; Sandecki A
    Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal exposure to stilbestrol and adenocarcinoma of the female genital tract: the pediatrician's responsibility.
    Soyka LF
    Pediatrics; 1975 Apr; 55(4):456-8. PubMed ID: 1128954
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of colposcopy in the examination of diethylstilbestrol-exposed women.
    Noller KL
    Obstet Gynecol Clin North Am; 1993 Mar; 20(1):165-76. PubMed ID: 8332308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol.
    Bornstein J; Adam E; Adler-Storthz K; Kaufman RH
    Obstet Gynecol Surv; 1988 Jan; 43(1):15-21. PubMed ID: 2829071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal adenosis. Factors influencing detection in a colposcopic evaluation.
    Burke L; Antonioli D
    Obstet Gynecol; 1976 Oct; 48(4):413-21. PubMed ID: 987558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer risk in DES-exposed offspring.
    Powell JL
    J Med Assoc Ga; 1979 May; 68(5):403-6. PubMed ID: 438682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.